| Dr Hector Juan Marchand Jr, MD | |
|
1231 Cumberland Xing, Valparaiso, IN 46383-2192 | |
| (219) 548-3843 | |
| (219) 548-3256 |
| Full Name | Dr Hector Juan Marchand Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 1231 Cumberland Xing, Valparaiso, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134474091 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4301101406 (Michigan) | Secondary |
| 207R00000X | Internal Medicine | 01075518A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| At Home Quality Care | Chesterton, IN | Home health agency |
| Porter Home Health | Valparaiso, IN | Home health agency |
| Elara Caring | South bend, IN | Home health agency |
| Northwest Health - Porter | Valparaiso, IN | Hospital |
| St Mary Medical Center Inc | Hobart, IN | Hospital |
| La Porte Hospital | La porte, IN | Hospital |
| Franciscan Health Crown Point | Crown point, IN | Hospital |
| Franciscan St Anthony Health - Michigan City | Michigan city, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Porter Physician Services Llc | 1850482407 | 91 |
| Rci (wrs), Llc. | 5092624510 | 312 |
News Archive
AstraZeneca and Nektar Therapeutics announced today that they have entered into an exclusive worldwide license agreement for two drug development programmes: NKTR-118, a late stage investigational product being evaluated for the treatment of opioid-induced constipation, and the NKTR-119 programme, an early stage programme that is intended to deliver products for the treatment of pain without constipation side effects.
African-American race is a distinct risk factor for developing life-threatening blood clots after receiving a drug-coated stent, according to research reported in Circulation: Journal of the American Heart Association.
The unprecedented rainfall from Hurricane Harvey in 2017 brought more than flood damage to southeast Texas.
Wednesday is World Malaria Day, observed annually on April 25. This year's theme is "Invest in the future: defeat malaria." The following is a summary of opinion pieces published in recognition of the day.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
› Verified 8 days ago
| Entity Name | Porter Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508075680 PECOS PAC ID: 1850482407 Enrollment ID: O20070810000409 |
News Archive
AstraZeneca and Nektar Therapeutics announced today that they have entered into an exclusive worldwide license agreement for two drug development programmes: NKTR-118, a late stage investigational product being evaluated for the treatment of opioid-induced constipation, and the NKTR-119 programme, an early stage programme that is intended to deliver products for the treatment of pain without constipation side effects.
African-American race is a distinct risk factor for developing life-threatening blood clots after receiving a drug-coated stent, according to research reported in Circulation: Journal of the American Heart Association.
The unprecedented rainfall from Hurricane Harvey in 2017 brought more than flood damage to southeast Texas.
Wednesday is World Malaria Day, observed annually on April 25. This year's theme is "Invest in the future: defeat malaria." The following is a summary of opinion pieces published in recognition of the day.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hector Juan Marchand Jr, MD 2022 Kelle Dr, Chesterton, IN 46304-8708 Ph: (219) 364-3616 | Dr Hector Juan Marchand Jr, MD 1231 Cumberland Xing, Valparaiso, IN 46383-2192 Ph: (219) 548-3843 |
News Archive
AstraZeneca and Nektar Therapeutics announced today that they have entered into an exclusive worldwide license agreement for two drug development programmes: NKTR-118, a late stage investigational product being evaluated for the treatment of opioid-induced constipation, and the NKTR-119 programme, an early stage programme that is intended to deliver products for the treatment of pain without constipation side effects.
African-American race is a distinct risk factor for developing life-threatening blood clots after receiving a drug-coated stent, according to research reported in Circulation: Journal of the American Heart Association.
The unprecedented rainfall from Hurricane Harvey in 2017 brought more than flood damage to southeast Texas.
Wednesday is World Malaria Day, observed annually on April 25. This year's theme is "Invest in the future: defeat malaria." The following is a summary of opinion pieces published in recognition of the day.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
› Verified 8 days ago
Dr. Mazen Zaitoon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 85 East United States 6 Frontage, Valparaiso, IN 46383 Phone: 219-983-8300 | |
Douglas Adolph Mazurek, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 Glendale Blvd, Suite 103, Valparaiso, IN 46383 Phone: 219-464-9054 Fax: 219-465-1749 | |
Michael Christopher Hansen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6, Valparaiso, IN 46383 Phone: 219-464-9054 Fax: 219-465-1749 | |
John Dougherty, Internal Medicine Medicare: Medicare Enrolled Practice Location: 56 Willow St, Valparaiso, IN 46383 Phone: 219-309-7254 | |
Dr. Akshay R. Trivedi, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2206 Roosevelt Rd Ste A, Valparaiso, IN 46383 Phone: 219-464-2285 | |
George E Sloan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Roosevelt Rd, Valparaiso, IN 46383 Phone: 219-464-1620 Fax: 219-477-4565 | |
Dr. Jay Shah, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 85 E Us Highway 6 Ste 300, Valparaiso, IN 46383 Phone: 219-983-6300 Fax: 219-263-7620 |